Most Recent
A judge has refused to summarily dismiss proceedings by collapsed construction group JM Kelly against its former accountant, finding it was an issue for trial whether he caused the company to continue operating despite financial issues leading to its liquidation.
A judge who oversaw a 39-day trial in 2018 in multiple class actions against S&P Global may be asked by the ratings agency to step down from hearing another class action alleging systemic defects in its ratings systems.
A small business owner has launched proceedings against his insurer claiming he was wrongly denied pandemic coverage under a business interruption policy, one of many cases expected to be filed in the wake a landmark ruling on infectious disease exclusions that could cost insurers $10 billion.
The Daily Mail wants to question sports presenter Erin Molan over a segment on Nine’s The Footy Show four years ago in which she laughed at an off-colour joke, as part of the publisher’s truth defence to Molan’s claims that she has been falsely labelled a racist.
A vegan, cruelty-free makeup company whose products are promoted by comedian Celeste Barber has been taken to court by a US company for allegedly selling a cheaper copycat version of its $42 concealer.
A judge has approved a "disappointing" $25 million settlement in long-running class action litigation over the collapse of electronics retailer Dick Smith with claims worth hundreds of millions of dollars.
The High Court will weigh in on a dispute between the Port of Newcastle and mining giant Glencore over access charges to shipping channels used to export coal from the Hunter Valley.
The High Court has rejected special leave applications by mining magnate Gina Rinehart to appeal a ruling which only partially stayed a legal dispute over ownership rights and royalties relating to the Rinehart family-owned Hope Downs iron ore mine, with one judge calling the mining magnate's arguments a "tortured articulation" and "very odd".
Ashurst has snagged a long-time commercial litigation partner from Clayton Utz as part of a planned “major expansion” of its disputes team.
Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company's top-selling MS drug Gilenya.